Page last updated: 2024-08-23

cabergoline and Pelvic Pain

cabergoline has been researched along with Pelvic Pain in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	2 (100.00)	2.80

Authors

Authors	Studies
Angioni, S; Carugno, J; Ciebiera, M; Ćorić, M; D'alterio, MN; Herman, M; Mikuš, M; Puževski, T; Vitale, SG; Zajec, V	1
Kogan, I; Molotkov, A; Suslova, E; Tkachenko, N; Yarmolinskaya, M	1

Reviews

1 review(s) available for cabergoline and Pelvic Pain

Article	Year
State of the art, new treatment strategies, and emerging drugs for non-hormonal treatment of endometriosis: a systematic review of randomized control trials. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2022, Volume: 38, Issue:11 Topics: Cabergoline; Dopamine Agonists; Endometriosis; Female; Humans; Pelvic Pain	2022

Trials

1 trial(s) available for cabergoline and Pelvic Pain

Article	Year
Dopamine agonists as genital endometriosis target therapy. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2020, Volume: 36, Issue:sup1 Topics: Adult; Ascitic Fluid; Cabergoline; Dopamine Agonists; Drug Therapy, Combination; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Molecular Targeted Therapy; Pelvic Pain; Peritoneal Diseases; Prolactin; Russia; Syndrome; Treatment Outcome	2020

Article

Year

Dopamine agonists as genital endometriosis target therapy.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2020, Volume: 36, Issue:sup1

Topics: Adult; Ascitic Fluid; Cabergoline; Dopamine Agonists; Drug Therapy, Combination; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Molecular Targeted Therapy; Pelvic Pain; Peritoneal Diseases; Prolactin; Russia; Syndrome; Treatment Outcome

2020